Author: Mori, Martina; Palumbo, Diego; De Lorenzo, Rebecca; Broggi, Sara; Compagnone, Nicola; Guazzarotti, Giorgia; Giorgio Esposito, Pier; Mazzilli, Aldo; Steidler, Stephanie; Pietro Vitali, Giordano; Del Vecchio, Antonella; Rovere Querini, Patrizia; De Cobelli, Francesco; Fiorino, Claudio
Title: Robust prediction of mortality of COVID-19 patients based on quantitative, operator-independent, lung CT densitometry Cord-id: uqo5ic39 Document date: 2021_4_30
ID: uqo5ic39
Snippet: PURPOSE: To train and validate a predictive model of mortality for hospitalized COVID-19 patients based on lung densitometry. METHODS: Two-hundred-fifty-one patients with respiratory symptoms underwent CT few days after hospitalization. “Aerated†(AV), “consolidated†(CV) and “intermediate†(IV) lung sub-volumes were quantified by an operator-independent method based on individual HU maximum gradient recognition. AV, CV, IV, CV/AV, IV/AV, and HU of the first peak position were extrac
Document: PURPOSE: To train and validate a predictive model of mortality for hospitalized COVID-19 patients based on lung densitometry. METHODS: Two-hundred-fifty-one patients with respiratory symptoms underwent CT few days after hospitalization. “Aerated†(AV), “consolidated†(CV) and “intermediate†(IV) lung sub-volumes were quantified by an operator-independent method based on individual HU maximum gradient recognition. AV, CV, IV, CV/AV, IV/AV, and HU of the first peak position were extracted. Relevant clinical parameters were prospectively collected. The population was composed by training (n = 166) and validation (n = 85) consecutive cohorts, and backward multi-variate logistic regression was applied on the training group to build a CT_model. Similarly, models including only clinical parameters (CLIN_model) and both CT/clinical parameters (COMB_model) were developed. Model’s performances were assessed by goodness-of-fit (H&L-test), calibration and discrimination. Model’s performances were tested in the validation group. RESULTS: Forty-three patients died (25/18 in training/validation). CT_model included AVmax (i.e. maximum AV between lungs), CV and CV/AE, while CLIN_model included random glycemia, C-reactive protein and biological drugs (protective). Goodness-of-fit and discrimination were similar (H&L:0.70 vs 0.80; AUC:0.80 vs 0.80). COMB_model including AVmax, CV, CV/AE, random glycemia, biological drugs and active cancer, outperformed both models (H&L:0.91; AUC:0.89, 95%CI:0.82–0.93). All models showed good calibration (R(2):0.77–0.97). Despite several patient's characteristics were different between training and validation cohorts, performances in the validation cohort confirmed good calibration (R(2):0–70-0.81) and discrimination for CT_model/COMB_model (AUC:0.72/0.76), while CLIN_model performed worse (AUC:0.64). CONCLUSIONS: Few automatically extracted densitometry parameters with clear functional meaning predicted mortality of COVID-19 patients. Combined with clinical features, the resulting predictive model showed higher discrimination/calibration.
Search related documents:
Co phrase search for related documents- absolute lymphocyte and acute ards respiratory distress syndrome: 1, 2, 3, 4
- absolute lymphocyte and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- absolute lymphocyte and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absolute lymphocyte and additional value: 1
- absolute lymphocyte and admission ct: 1
- absolute lymphocyte and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- absolute lymphocyte and lopinavir ritonavir: 1
- absolute lymphocyte and low number: 1
- absolute lymphocyte and lung involvement: 1, 2, 3, 4, 5
- absolute lymphocyte and machine learning: 1, 2
- acceptably low and logistic regression: 1
- active cancer and acute ards respiratory distress syndrome: 1, 2
- active cancer and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- active cancer and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- active cancer and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- active cancer and lopinavir ritonavir: 1, 2, 3
- active cancer and low number: 1, 2, 3
- active cancer and lung involvement: 1, 2, 3, 4, 5
- active cancer and machine learning: 1
Co phrase search for related documents, hyperlinks ordered by date